Rory B. Riggs, Director at Royalty Pharma plc (RPRX), sold 444,893 shares at $40.00 ($11.8M) on 2021-12-29, disclosed to the SEC on 2021-12-30.
Open-market sale of $11.8M RPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 150,997 | $0 | 0.0% |
| 2 | $40.21 | 26,677 | $1.1M | 9.1% |
| 3 | $40.21 | 26,677 | $1.1M | 9.1% |
| 4 | $40.21 | 35,193 | $1.4M | 12.0% |
| 5 | $40.21 | 35,193 | $1.4M | 12.0% |
| 6 | $40.21 | 47,578 |
| $1.9M |
| 16.2% |
| 7 | $40.21 | 47,578 | $1.9M | 16.2% |
| 8 | $40.00 | 75,000 | $3.0M | 25.4% |
| Total | $26.53 avg | 444,893 | $11.8M | 100% |
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |